Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
Recruiting
Phase 1
Phase 2
Interventional Study
Insulin Resistance Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 55 – 65
- Sex
- Female
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background: In postmenopausal females, Insulin resistance is commonly encountered in clinical setting. Hyperbaric oxygen therapy have been proposed effective in lowering blood glucose level and improving function. Identification of clinical examination variables as predictors to blood glucose levels and dysfunction would offer therapists the chance to undertake clinical decisions and consequently …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* A)Inclusion Criteria
* All females were clinically diagnosed with Postmenopausal Insulin resistance.
* Their ages were ranged from 55-65 years old.
* Their BMI was 30-34.9 kg/m².
* All patients should had controlled blood glucose levels by oral hypoglycemic drugs.
*…
Contacts
Siham mohamed fahmy Head of Hyperbaric oxygen therapy unit, Assistant professor
01033380185
CONTACT
Kobry el koba military complex Kobry el koba military complex, Military Medical complex
0222638885
CONTACT